Hoff M, Gulati AM, Romundstad PR et al (2015) Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag health study (HUNT). Ann Rheum Dis 74:60–64. https://doi.org/10.1136/ANNRHEUMDIS-2013-203862

Article  PubMed  Google Scholar 

Kerola AM, Rollefstad S, Kazemi A et al (2023) Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scand J Rheumatol 52:42–50. https://doi.org/10.1080/03009742.2021.1997436

Article  CAS  PubMed  Google Scholar 

Campanholo CB, Maharaj AB, Corp N et al (2022) Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol jrheum. https://doi.org/10.3899/JRHEUM.220310

Article  Google Scholar 

Lee S, Mendelsohn A, Sarnes E (2010) The burden of psoriatic arthritis: a literature review from a global health systems perspective. Pharmacy and Therapeutics 35:680

PubMed  PubMed Central  Google Scholar 

Gottlieb A, Gratacos J, Dikranian A et al (2019) Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe. Rheumatol Int 39:121–130. https://doi.org/10.1007/S00296-018-4195-X/TABLES/2

Article  PubMed  Google Scholar 

Michelsen B, Uhlig T, Sexton J et al (2018) Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis 77:1290–1294. https://doi.org/10.1136/ANNRHEUMDIS-2018-213286

Article  PubMed  Google Scholar 

Haugeberg G, Michelsen B, Tengesdal S et al (2018) Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther. https://doi.org/10.1186/S13075-018-1659-Z

Article  PubMed  PubMed Central  Google Scholar 

Kavanaugh A, Gottlieb A, Morita A et al (2019) The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies. Ann Rheum Dis 78:1215–1219. https://doi.org/10.1136/ANNRHEUMDIS-2018-215003

Article  PubMed  Google Scholar 

Haugeberg G, Michelsen B, Kavanaugh A (2020) Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: a cross-sectional study of outpatient clinic patients in the biologic treatment era. RMD Open. https://doi.org/10.1136/RMDOPEN-2020-001223

Article  PubMed  PubMed Central  Google Scholar 

Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673. https://doi.org/10.1002/ART.21972

Article  PubMed  Google Scholar 

Michelsen B, Diamantopoulos AP, Høiberg HK et al (2017) Need for improvement in current treatment of psoriatic arthritis: study of an outpatient clinic population. J Rheumatol 44:431–436. https://doi.org/10.3899/JRHEUM.160973

Article  PubMed  Google Scholar 

Łosińska K, Michelsen B, Kavanaugh A et al (2023) Psoriatic arthritis: improvement in outcomes but persistent sex difference - 5-year follow-up study of a Norwegian outpatient clinic population. Scand J Rheumatol. https://doi.org/10.1080/03009742.2023.2247703

Article  PubMed  Google Scholar 

Sokka T (2016) Go, go, GoTreatIT! Clin Exp Rheumatol 34:91–95

Google Scholar 

Schoels M, Aletaha D, Funovits J et al (2010) Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69:1441–1447. https://doi.org/10.1136/ARD.2009.122259

Article  PubMed  Google Scholar 

Pincus T, Summey JA, Soraci SA et al (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346–1353. https://doi.org/10.1002/ART.1780261107

Article  CAS  PubMed  Google Scholar 

Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional health assessment questionnaire (MDHAQ) assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42:2220–2230. https://doi.org/10.1002/1529-0131

Article  CAS  PubMed  Google Scholar 

Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336. https://doi.org/10.3109/07853890109002086

Article  CAS  PubMed  Google Scholar 

Saarni SI, Härkänen T, Sintonen H et al (2006) The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 15:1403–1414. https://doi.org/10.1007/S11136-006-0020-1

Article  PubMed  Google Scholar 

Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210–216. https://doi.org/10.1111/J.1365-2230.1994.TB01167.X

Article  CAS  PubMed  Google Scholar 

Kavanaugh A, Helliwell P, Ritchlin CT (2016) Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatol Ther 3:91–102. https://doi.org/10.1007/S40744-016-0029-Z

Article  PubMed  PubMed Central  Google Scholar 

Kawalec P, Malinowski KP, Pilc A (2016) Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland. Rheumatol Int 36:1223–1230. https://doi.org/10.1007/S00296-016-3514-3/TABLES/6

Article  PubMed  PubMed Central  Google Scholar 

Merola JF, Dennis N, Chakravarty SD et al (2021) Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 to 2020. Clin Rheumatol 40:4061–4070. https://doi.org/10.1007/S10067-021-05713-8

Article  CAS  PubMed  Google Scholar 

Sokoll KB, Helliwell PS (2001) Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 28:1842–1846

CAS  PubMed  Google Scholar 

Salaffi F, Carotti M, Gasparini S et al (2009) The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes. https://doi.org/10.1186/1477-7525-7-25

Article  PubMed  PubMed Central  Google Scholar 

Wilk M, Łosińska K, Pripp AH et al (2022) Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life. Rheumatol Int 42:669–682. https://doi.org/10.1007/S00296-021-05070-4

Article  PubMed  Google Scholar 

Orbai AM, De Wit M, Mease PJ et al (2017) Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol 44:1522–1528. https://doi.org/10.3899/jrheum.160904

Article  PubMed  PubMed Central  Google Scholar 

Leung YY, Tillett W, Orbai AM et al (2020) The GRAPPA-OMERACT Working Group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates. J Rheumatol Suppl 96:46–49. https://doi.org/10.3899/JRHEUM.200127

Article  PubMed  Google Scholar 

Dubertret L, Mrowietz U, Ranki A et al (2006) European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 155:729–736. https://doi.org/10.1111/J.1365-2133.2006.07405.X

Article  CAS  PubMed  Google Scholar 

Coates LC, O’Dwyer J, Meads D et al (2022) Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era. Lancet Rheumatol 4:e390–e391. https://doi.org/10.1016/S2665-9913(22)00101-1

Article  CAS  PubMed  Google Scholar 

Lu Y, Dai Z, Lu Y, Chang F (2022) Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis. BMJ Open 12:e058497. https://doi.org/10.1136/BMJOPEN-2021-058497

Article  PubMed  PubMed Central  Google Scholar 

Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41:275. https://doi.org/10.1007/S00296-020-04775-2

Article  PubMed  PubMed Central  Google Scholar 

Yim KM, Armstrong AW (2017) Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int 37:97–105. https://doi.org/10.1007/S00296-016-3487-2/METRICS

Article  CAS  PubMed  Google Scholar 

Patel P, Rosen CF, Chandran V et al (2018) Addressing comorbidities in psoriatic disease. Rheumatol Int 38:219–227. https://doi.org/10.1007/S00296-017-3895-Y/METRICS

Article  PubMed  Google Scholar 

Eder L, Gladman DD (2015) Atherosclerosis in psoriatic disease: latest evidence and clinical implications. Ther Adv Musculoskelet Dis 7:187. https://doi.org/10.1177/1759720X15591801

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yilmazer B, Sahin T, Unlu BÖ et al (2015) Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int 35:1385–1392. https://doi.org/10.1007/S00296-015-3228-Y/METRICS

Article  CAS